User testing to modify the MyHealthyGut digital health application for inflammatory bowel disease
Introduction Inflammatory bowel disease, characterized by chronic intestinal inflammation, can be subcategorized into Crohn's disease and ulcerative colitis. The treatment for these conditions is unique to each patient and may include lifestyle changes, pharmaceutical intervention, and surgery....
Main Authors: | Madeline Erlich, Sarah Lindblad, Natasha Haskey, Darlene Higbee Clarkin, Taojie Dong, Ruth Harvie, Genelle Lunken, Jess Pirnack, Kevan Jacobson |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-09-01
|
Series: | Digital Health |
Online Access: | https://doi.org/10.1177/20552076231203664 |
Similar Items
-
Therapeutic Advances in Gut Microbiome Modulation in Patients with Inflammatory Bowel Disease from Pediatrics to Adulthood
by: Adi Eindor-Abarbanel, et al.
Published: (2021-11-01) -
Fiber and Prebiotic Interventions in Pediatric Inflammatory Bowel Disease: What Role Does the Gut Microbiome Play?
by: Genelle R. Healey, et al.
Published: (2020-10-01) -
MyHealthyGut: Findings from a pilot randomized controlled trial on adherence to a gluten-free diet and quality of life among adults with celiac disease or gluten intolerance
by: A Justine Dowd, et al.
Published: (2020-01-01) -
Gut microbiome-associated predictors as biomarkers of response to advanced therapies in inflammatory bowel disease: a systematic review
by: Susanna Meade, et al.
Published: (2023-12-01) -
To Fiber or Not to Fiber: The Swinging Pendulum of Fiber Supplementation in Patients with Inflammatory Bowel Disease
by: Natasha Haskey, et al.
Published: (2023-02-01)